What You Should Know:
- Gradient AI, a leading enterprise software provider of artificial intelligence (AI) solutions in the insurance industry, recently announced that it has acquired Prognos Health’s analytics business underwriting unit to leverage data from the company’s large collection of integrated medical records and lab data via its real-world data marketplace.
- The acquisition will enable Gradient AI to expand its medical database capabilities by integrating Prognos Health’s data
Read More
Prognos
Evidation’s Appoints Co-CEO, Greenway’s New President, Other Health IT Appointments
Evidation’s Board of Directors has appointed Christine Lemke as Co-CEO alongside Executive Chair Deborah Kilpatrick.
Greenway Health appoints Pratap Sarker as President to oversee all commercial and customer-focused functions including sales, marketing, and customer success. He will also work closely with Greenway’s clearinghouse, revenue cycle and IT teams to ensure the delivery of quality solutions that are critically needed to support practices’ business continuity, as well as their
Read More
Livongo, Prognos Health Integrate for Members to View Clinical Lab Data Insights
What You Should Know:
- Livongo partners with Prognos Health to drive more personalized health nudges with clinical laboratory analytics at scale, allowing Livongo members to share their test results from leading commercial labs.
- By partnering with Prognos, Livongo now offers Members the ability to easily view their important clinical laboratory data on the Livongo platform.
- In addition, Livongo’s AI+AI® engine is now powered by lab test values,
Read More
Prognos, Datavant Partner to Use Health Data Ecosystem to Enhance AI Analytics for Customers
Prognos, an AI-powered analytics for early tracking and prediction of disease, today announced that it will partner with Datavant, the company helping healthcare organizations safely connect their data. Prognos will be able to harness Datavant's comprehensive ecosystem in delivering analytics solutions, expanding the data that customers can readily access to better inform clinical decisions, identify risk, enhance care quality, and improve patient outcomes.In order to determine and predict
Read More
Prognos Raises $20.5M For AI-Powered Disease Prediction Platform for Payers, Providers
Prognos, a New York City-based healthcare Artificial Intelligence (AI) startup that has been steadfastly building its AI capabilities with the goal of predicting disease has raised $20.5 million in Series C funding. Particpatnts in the round include Cigna, GIS Strategic Ventures (the venture capital arm of the Guardian Life Insurance Company), Hermed, Hikma Ventures, Maywic, Merck Global Health Innovation Fund (GHI), and Safeguard Scientifics.Prognos plans to use the funding to expand Prognos’
Read More
Medivo Rebrands as Prognos to Leverage AI for Earlier Disease Detection
After six years of research and development exploring the potential of clinical diagnostic assets, Medivo has rebranded as Prognos. The new artificial intelligence-focused company mission is to help payer, life sciences and diagnostics organization track and predict disease earlier through advanced analytics and artificial intelligence techniques. The company is supported by a $23M investment from Safeguard Scientifics, Inc. and Merck Global Health Innovation Fund (GHIF).Prognos has already
Read More
